This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Events

Flynn Pharma is committed to the delivery of high quality education and supporting the continued development of healthcare professionals – it’s our way of helping you to help your patients.

Back

This educational and promotional event is organised and funded by Flynn Pharma Ltd.

Untangling the overlap between ASD and ADHD

This event took place on Wednesday 10 July 2024

Slenyto® (Prolonged-release melatonin) Prescribing InformationMeflynate® XL (Methylphenidate hydrochloride) Prescribing Information
Your certificate will be available in your account once you have watched the on-demand video.

Agenda

Untangling the overlap between ASD and ADHD, Dr Juan Claudio Ferre Vidal, Consultant Child and Adolescent Psychiatrist, Neurodevelopmental Service, Cardiff and Vale University Health Board
Dr Juan Claudio Ferre Vidal
Dr Juan Claudio Ferre Vidal
LMS, MRCPsych

Dr Juan Claudio Ferre Vidal is a Consultant in Child and Adolescent Psychiatry working full-time in the Neurodevelopmental Service (Community Child Health) in Cardiff and the Vale UHB. After nearly 15 years working in CAMHS, both in the UK as well as in Spain for a while, Dr Vidal moved to the newly created Neurodevelopmental Service 7 years ago.

What will the webinar cover?

Key learning objectives

  • To provide an update on medications for children with ASD and ADHD